Get started
ABBVIEABBVIEABBVIE

ABBVIE

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals Bonds

4ABBV trade ideas

ABBV - Test the trendlineAs we can see from the chart, the price now is testing the bearish trendline which had stood for months. Besides, ABBV crossed the 70, the old resistance which can only be seen if switching to Weekly chart. Next, the price now is being supported by a bullish trendline. There are 2 strategies: 1. Wait for the price to test the up-ward trendline again, and start a long position. 2. Wait for the price to break the bearish trendline, and go long The target price for both is 76 - to close the gap and meet a strong resistance these months in 2019.
NYSE:ABBVLong
by ThanhhLong
Good time to buy ABBVIEChart Analyse Based on weekly and monthly chart, we can see an interesting point in the ABBVIE chart. The weekly chart is showing a nice low currently forming. Lets see how we end this week. And if we look at the long term trend, the low sits exactly on the long term trend line. If we look at the monthly timeframe you can see also a nice candle forming. we still have a week to go this month, so lets see what happens. Additionally, this corresponds to Fibonacci zone 78.6 Dividend currently 6.4 % Dividend 6 year growth history good payout ratio 1 year dividend growth 27 %
NYSE:ABBVLong
by MH77
1
ABBV: Ex-Dividend Put Play for 7/12 ONLYHi All, I am testing this Ex-Dividend Put Play after a huge success in doing AT&T (T) dividend play. ABBV is to distribute $1.07 as a dividend, and on the ex-dividend date, that much will be subtracted from the share price. ABBV closed at $71.24 and subtracting $1.07, let's hope that tomorrow, it will open around $70.17 without calculating other factors. If this goes as a success, I will try to post more ex-dividend put plays so you all can join at your own risk.
NYSE:ABBVShort
by Opportunistock
Investors see the upside to Allergan deal, Bullish above $77As usual once a deal is announced the acquirers stock price automatically drops, then those that sold realise that the company knows more than them and the acquisition is actually beneficial, thus the price shoots back up. Currently old support is acting as resistance but we think not for long and a break above will be very positive in the near term, providing a nice long trade opportunity. Alerts set for break of $77 in anticipation of strong move to $87 target. Remember that Botox brings big $$$$$.
NYSE:ABBVLong
by RedHotStocks
2